(44) which also showed that circulating ANGPTL8 levels in patients with NAFLD were significantly higher compared to those in individuals without a NAFLD diagnosis (SMD: 0.97, 95% CI: 0.77, 1.18). The gene discussed is ANGPTL8; the disease is metabolic dysfunction-associated steatotic liver disease.